Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 5/20 | 0.78 |
| ▸ | CA1 | P00915 | 4/20 | 0.78 |
| ▸ | MGLL | Q99685 | 2/20 | 0.78 |
| ▸ | ENPP2 | Q13822 | 6/20 | 0.61 |
| ▸ | LPL | P06858 | 3/20 | 0.58 |
| ▸ | LIPG | Q9Y5X9 | 3/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | CA4 | P22748 | 1/20 | 0.56 |
| ▸ | CA6 | P23280 | 1/20 | 0.56 |
| ▸ | CA5A | P35218 | 1/20 | 0.56 |
| ▸ | CA7 | P43166 | 1/20 | 0.56 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.56 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | F11 | P03951 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13667445 | 1.00 | CA2 (0.78) | CA2CA1MGLLENPP2LPL | |
| SCHEMBL18394607 | 1.00 | CA2 (0.78) | CA2CA1MGLLENPP2LPL | |
| SCHEMBL29262949 | 0.97 | CA2 (0.74) | CA2CA1MGLLENPP2LPL | |
| SCHEMBL806612 | 0.91 | CA2 (0.67) | CA2CA1MGLLENPP2LPL | |
| SCHEMBL204921 | 0.89 | ENPP2 (0.73) | CA2CA1MGLLENPP2LPL | |
| Biphenylboronic Acid SCHEMBL129728 | 0.88 | CA2 (1.00) | CA2CA1MGLLENPP2LPL | |
| SCHEMBL18459963 | 0.88 | ENPP2 (0.83) | CA2CA1MGLLENPP2LPL | |
| SCHEMBL22361777 | 0.88 | ENPP2 (0.83) | CA2CA1MGLLENPP2LPL | |
| SCHEMBL25665366 | 0.88 | CA2 (1.00) | CA2CA1MGLLENPP2LPL | |
| SCHEMBL12860012 | 0.88 | CA2 (1.00) | CA2CA1MGLLENPP2LPL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 547 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122011773-A | Dynamic reworkable high-heat-conductivity low-dielectric composite material and preparation method and application thereof | 华东理工大学 | 2026-05-12 | — | — | CN | claimed |
| US-20250194617-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-06-19 | — | — | US | claimed |
| US-20250169514-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-05-29 | — | — | US | claimed |
| CN-116284764-B | Preparation method of metal coordinated benzene ring-rich organic polymer material | 上海大学 | 2025-05-13 | — | — | CN | claimed |
| CN-119613637-A | Preparation process of anti-cracking polycarboxylate superplasticizer | 山西格瑞特建筑科技股份有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-119529810-A | Drag reducer for fracturing and preparation method thereof | 郑州德融科技有限公司 | 2025-02-28 | — | — | CN | claimed |
| WO-2024242974-A1 | ADDITIVE MANUFACTURING OF COVALENT ORGANIC FRAMEWORK DEVICES VIA AEROSOL JET PRINTING OF COLLOIDALLY STABLE INKS AND APPLICATIONS OF SAME | NORTHWESTERN UNIVERSITY (US) | 2024-11-28 | — | — | WO | claimed |
| CN-118185002-A | Method for synthesizing aniline covalent organic polymer | 玉林师范学院 | 2024-06-14 | — | — | CN | claimed |
| CN-118185046-A | Preparation method of self-repairing material based on reinforced and toughened covalent organic framework filler | 安徽工业大学 | 2024-06-14 | — | — | CN | claimed |
| CN-115010906-B | Synthesis method of porous covalent organic framework material with TNP structure | 河南科技大学 | 2024-05-28 | — | — | CN | claimed |
| US-20100099586-A1 | BORON CROSSLINKERS FOR FRACTURING FLUIDS WITH APPRECIABLY LOWER POLYMER LOADING | BJ ENERGY SOLUTIONS, LLC | 2010-04-22 | — | — | US | claimed |
| US-20100040538-A1 | Polymer Systems for Lung Volume Reduction Therapy | CANADIAN IMPERIAL BANK OF COMMERCE (CA) | 2010-02-18 | — | — | US | claimed |
| EP-2059227-A2 | POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY | Aeris Therapeutics, Inc. (US) | 2009-05-20 | — | — | EP | claimed |
| WO-2008039827-A2 | POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY | AERIS THERAPEUTICS, INC. (US) | 2008-04-03 | — | — | WO | claimed |
| US-6800784-B1 | REACTING AROMATIC COMPOUND CARRYING AT LEAST ONE AMINO GROUP AND LEAVING GROUP WITH ARYLBORONIC ACID OR DERIVATIVE THEREOF, IN AQUEOUS MEDIUM, AND IN PRESENCE OF EFFECTIVE QUANTITY OF PALLADIUM CATALYST | RHODIA CHIMIE (FR) | 2004-10-05 | — | — | US | claimed |
| EP-1107982-B1 | REVERSIBLE BORON COMPLEXES OF 1,2-(CIS)-DIOL CYCLIC PEPTIDES | LILLY CO ELI (US) | 2004-05-19 | — | — | EP | claimed |
| US-6590100-B2 | Reacting an aromatic compound bearing a leaving group and an arylboronic acid and/or its derivatives in the presence of a base and an effective amount of a nickel catalyst | RHODIA CHIMIE (FR) | 2003-07-08 | — | — | US | claimed |
| US-20020173652-A1 | Process for preparing a polyaromatic compound | SHASUN PHARMA SOLUTIONS, INC. | 2002-11-21 | — | — | US | claimed |
| EP-1107982-A1 | REVERSIBLE BORONATE COMPLEXES OF 1,2-$i(CIS)-DIOL CYCLIC-PEPTIDES | Eli Lilly & Company (US) | 2001-06-20 | — | — | EP | claimed |
| WO-2000012540-A1 | REVERSIBLE BORONATE COMPLEXES OF 1,2-CIS-DIOL CYCLIC-PEPTIDES | ELI LILLY AND COMPANY (US) | 2000-03-09 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100040538-A1 | Polymer Systems for Lung Volume Reduction Therapy | GFER, MUC1, CTH | CA2 2856/4885CA1 1918/4885MGLL 2208/4885 |
| US-20020173652-A1 | Process for preparing a polyaromatic compound | PAH, ALK, ITPA | CA2 2394/4885CA1 2616/4885MGLL 3922/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.